Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension

Journal of Applied Physiology

Volumn 109, Issue 6, 2010, Pages 1998-2000

  Navar, L Gabriel ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADRENERGIC SYSTEM; ANIMAL; ARTICLE; BLOOD PRESSURE; DRUG EFFECT; HUMAN; HYPERTENSION; INNERVATION; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION; KIDNEY; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 78651277558     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00182.2010a     Document Type: Article

References (30)

1. Bakris GL, Toto RD, McCullough PA, Rocha R, Purkayastha D, Davis P. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. Kidney Int 73:1303-1309, 2008.
2. Burke SL, Evans RG, Moretti JL, Head GA. Levels of renal and extrarenal sympathetic drive in angiotensin II-induced hypertension. Hypertension 51:878-883, 2008.
3. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA 103:17985-17990, 2006.
4. Davisson RL, Yang G, Beltz TG, Cassell MD, Johnson AK, Sigmund CD. The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ Res 83:1047-1058, 1998.
5. DiBona GF. The sympathetic nervous system and hypertension: recent developments. Hypertension 43:147-150, 2004.
6. Esler M, Lampber E, Schlaich M. Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. J Appl Physiol; doi:10.1152/japplphysiol.00182.2010.
7. Fisher ND, Hollenberg NK. Renin inhibition: what are the therapeutic opportunities? J Am Soc Nephrol 16:592-599, 2005.
8. Gonzalez-Villalobos RA, Seth DM, Satou R, Horton H, Ohashi N, Miyata K, Katsurada A, Tran DV, Kobori H, Navar LG. Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice. Am J Physiol Renal Physiol 295: F772-F779, 2008.
9. Guidi E, Menghetti D, Milani S, Montagnino G, Palazzi P, Bianchi G. Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families. J Am Soc Nephrol 7:1131-1138, 1996.
10. Guyton AC. Blood pressure control-special role of the kidneys and body fluids. Science 252:1813-1816, 1991.
11. Ichihara A, Inscho EW, Imig JD, Michel RE, Navar LG. Role of renal nerves in afferent arteriolar reactivity in angiotensin-induced hypertension. Hypertension 29:442-449, 1997.
12. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59:251-287, 2007.
13. Kobori H, Prieto-Carrasquero MC, Ozawa Y, Navar LG. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 43:1126-1132, 2004.
14. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373:1275-1281, 2009.
15. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, Harrison DG. Role of p47 (phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40:511-515, 2002.
16. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 104:545-556, 2001.
17. Mitchell KD, Braam B, Navar LG. Hypertensinogenic mechanisms mediated by renal actions of renin-angiotensin system. Hypertension 19, Suppl I: I-18-I-27, 1992.
18. Moretti JL, Burke SL, Evans RG, Lambert GW, Head GA. Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension. J Hypertens 27:1838-1848, 2009.
19. Navar LG, Hamm LL. The kidney in blood pressure regulation. In: Atlas of Diseases of the Kidney. Hypertension and the Kidney, edited by Wilcox CS. Philadelphia: Current Medicine, 1999, p. 1.1-1.22.
20. 1 receptor blockers. In: Angiotensin II Receptor Antagonists, edited by Epstein M and Brunner HR. Philadelphia: Hanley & Belfus, 2000, p. 189-214.
21. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 39:316-322, 2002.
22. Navar LG, Ploth DW. Pathophysiology of renovascular hypertension. In: Hypertension Primer: The Essentials of High Blood Pressure, edited by Izzo JL, Black HR, and Sica DA. Philadelphia: Lippincott Williams & Wilkins, 2008, p. 162-165.
23. Prieto-Carrasquero MC, Botros FT, Pagan J, Kobori H, Seth DM, Casarini DE, Navar LG. Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip Goldblatt hypertensive rats. Hypertension 51:1590-1596, 2008.
24. Prieto-Carrasquero MC, Kobori H, Navar LG. The intrarenal reninangiotensin system. In: Hypertension and Hormone Mechanisms, edited by Carey RM. Totowa, NJ: Humana, 2007, p. 3-22.
25. Rohrwasser A, Morgan T, Dillon HF, Zhao L, Callaway CW, Hillas E, Zhang S, Cheng T, Inagami T, Ward K, Terreros DA, Lalouel JM. Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension 34:1265-1274, 1999.
26. Rossier BC, Schild L. Epithelial sodium channel: Mendelian versus essential hypertension. Hypertension 52:595-600, 2008.
27. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, Egido J. Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 38:1382-1387, 2001.
28. Schunkert H, Ingelfinger JR, Jacob H, Jackson B, Bouyounes B, Dzau VJ. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol Endocrinol Metab 263: E863-E869, 1992.
29. Touyz RM. The role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep 5:155-164, 2003.
30. Zhao D, Seth DM, Navar LG. Enhanced distal nephron sodium reabsorption in chronic angiotensin II-infused mice. Hypertension 54:120-126, 2009.